loading

Capricor Therapeutics Inc (CAPR) 最新ニュース

pulisher
Jun 18, 2025

US FDA’s Top Cell and Gene Therapy Regulators Forced Out - insights.citeline.com

Jun 18, 2025
pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

Capricor gets FDA's Orphan Drug status for muscle disorder therapy - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Capricor Therapeutics Announces Orphan Drug Designation for - GlobeNewswire

Jun 18, 2025
pulisher
Jun 17, 2025

Capricor Therapeutics (CAPR) Rating Reiterated by Roth Capital | CAPR Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Capricor Therapeutics (CAPR) Gains FDA Orphan Drug Status for Deramiocel - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc.CAPR - PR Newswire

Jun 17, 2025
pulisher
Jun 17, 2025

Capricor Therapeutics' Deramiocel Wins FDA Orphan Drug Designation for Becker Muscular Dystrophy - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Capricor Therapeutics (CAPR) Receives Orphan Drug Designation for BMD Treatment | CAPR Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Capricor Scores Double Win: FDA Orphan Drug Status for Becker MD Plus DMD Approval Progress - Stock Titan

Jun 17, 2025
pulisher
Jun 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor ... - Eagle-Tribune

Jun 15, 2025
pulisher
Jun 14, 2025

FDA Grants Orphan Status to Capricor's Becker Muscular Dystrophy Treatment (CAPR) | CAPR Stock News - GuruFocus

Jun 14, 2025
pulisher
Jun 14, 2025

Capricor Therapeutics (CAPR) Shares Dip Seen as Buying Opportuni - GuruFocus

Jun 14, 2025
pulisher
Jun 14, 2025

Capricor Therapeutics (CAPR) Sees Unusual Put Activity | CAPR St - GuruFocus

Jun 14, 2025
pulisher
Jun 13, 2025

Capricor (CAPR) Shares Decline Amid FDA Advisory Panel Developments | CAPR Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Capricor Therapeutics (CAPR) Receives Buy Rating from HC Wainwri - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Capricor Therapeutics (CAPR) Receives Buy Rating from HC Wainwright & Co. | CAPR Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Capricor Therapeutics (CAPR) Shares Drop After FDA Withdraws Mee - GuruFocus

Jun 13, 2025
pulisher
Jun 12, 2025

Capricor gets Form 483 from FDA; WuXi Biologics’ new China factory - Endpoints News

Jun 12, 2025
pulisher
Jun 12, 2025

Capricor says FDA inspection brought Form 483 with several observations - Yahoo Finance

Jun 12, 2025
pulisher
Jun 11, 2025

Capricor Therapeutics (CAPR) Manufacturing Facility Cleared by F - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor Therapeutics (CAPR) Shares Decline Amid FDA Inspection Report - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor Therapeutics (CAPR) Advances Deramiocel Approval Proces - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor: A Hold Rating With Regulatory FDA Form Given For Deramiocel Advancement (CAPR) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor Therapeutics Announces Key Regulatory Updates for its D - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

FDA Completes Inspection of Capricor Therapeutics Manufacturing Facility For Deramiocel Approval: Retail Sees ‘Unimaginable Potential’ - Asianet Newsable

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor Therapeutics (CAPR) Manufacturing Facility Cleared by FDA | CAPR Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor Therapeutics' Duchenne Therapy Facility Inspection Completed by FDA - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor falls after facility inspection related to deramiocel - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor Therapeutics stock falls after FDA inspection of manufacturing facility - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor Therapeutics stock falls after FDA inspection of manufacturing facility By Investing.com - Investing.com Nigeria

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor’s DMD therapy clears FDA pre-license inspection By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Capricor's DMD Drug Hits 3 Major FDA Milestones: Advisory Committee Set for July 30 - Stock Titan

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Estimates CAPR FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Behind the Scenes of Capricor Therapeutics's Latest Options Trends - Benzinga

Jun 10, 2025
pulisher
Jun 09, 2025

(CAPR) Trading Signals - news.stocktradersdaily.com

Jun 09, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Purchases New Position in Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Capricor Therapeutics Sees Unusually High Options Volume (NASDAQ:CAPR) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Capricor Therapeutics, Inc.CAPR - FinancialContent

Jun 06, 2025
pulisher
Jun 05, 2025

Capricor Therapeutics (CAPR) Sees Borrow Rate Surge | CAPR Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Millennium Management LLC Acquires 12,285 Shares of Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Reduces Stake in Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Capricor Therapeutics, Inc. (CAPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

Two Sigma Investments LP Has $1.64 Million Stake in Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Bank of America Corp DE Purchases 154,127 Shares of Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeutics, Inc. (CAPR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 02, 2025
pulisher
Jun 01, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Capricor Therapeutics, Inc. (CAPR) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 01, 2025
pulisher
May 31, 2025

Capricor Therapeutics Inc (NASDAQ:CAPR) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 31, 2025
pulisher
May 31, 2025

Deutsche Bank AG Takes Position in Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World

May 31, 2025
pulisher
May 30, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Capricor Therapeutics, Inc. (CAPR) And Encourages Shareholders to Reach Out - ACCESS Newswire

May 30, 2025
pulisher
May 29, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeutics, Inc. (CAPR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 28, 2025

(CAPR) Technical Data - news.stocktradersdaily.com

May 28, 2025
pulisher
May 28, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Capricor Therapeutics, Inc. (CAPR) and Encourages Investors to Learn More About the Investigation - Louisiana First News

May 28, 2025
pulisher
May 27, 2025

Capricor Therapeutics, Inc. (CAPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

May 27, 2025
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):